IP Library › Granted Patent US 12,727,946
Granted Patent B2
US 12,727,946 · App. 19/053,680 · Granted Sep 8, 2026

Orthopaedic implant systems including transfer features and methods for plan transfer

Inventors: Nick Metcalfe (Bonita Springs, FL); Steven Jim DeLeon (Naples, FL)
Assignee: ARTHREX, INC.
A61B34/10A61B17/1725A61B17/56A61B2034/102A61B2034/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,946
App. No.
19/053,680
Granted
Sep 8, 2026
Kind
B2
Abstract

This disclosure relates to planning systems, assemblies and methods. The planning systems, assemblies and methods disclosed herein may be utilized for planning and implementing orthopaedic procedures to restore functionality to a joint, and may include one or more transfer members for positioning implants relative to patient anatomy.

Claims (14)

1 . An orthopaedic implant comprising:

a baseplate including a plate body extending along an implant axis between a front face and a rear face;

an augment extending outwardly from the rear face of the baseplate, the augment dimensioned to contact bone; and

one or more transfer members extending from the augment and coupled to the augment at a respective breakable connection, wherein the one or more transfer members are configured to contact bone, and wherein the one or more transfer members include a first portion extending radially outward from a periphery of the augment relative to the implant axis and a second portion extending axially from the first portion relative to the implant axis.

2 . The implant as recited in claim 1 , wherein the one or more transfer members are dimensioned based on a predetermined surgical plan.

3 . The implant as recited in claim 1 , wherein the one or more transfer members are integrally formed with the augment.

4 . The implant as recited in claim 1 , wherein the augment is formed along the baseplate.

5 . The implant as recited in claim 1 , wherein the breakable connection is configured to sever in response to a predetermined quantity of torque at an interface.

6 . The implant as recited in claim 5 , wherein the breakable connection is configured to sever in response to the predetermined quantity of torque in a first rotational direction with respect to an axis extending through the interface, but not a second rotational direction opposed to the first rotational direction.

7 . The implant as recited in claim 1 , wherein the one or more transfer members include a plurality of transfer members circumferentially distributed about the periphery of the augment.

8 . The implant as recited in claim 7 , wherein each of the transfer members includes a terminal end portion configured to contact tissue.

9 . The implant as recited in claim 8 , wherein the breakable connection is configured to sever in response to a predetermined quantity of torque in a first rotational direction with respect to an axis extending through the second portion, but not a second rotational direction opposed to the first rotational direction.

10 . The implant as recited in claim 1 , wherein the baseplate includes a central aperture and a plurality of peripheral apertures circumferentially distributed about the central aperture, the peripheral apertures are aligned with respective passages through the augment and are dimensioned to receive respective fasteners partially receivable through the respective passages and into bone.

11 . The implant as recited in claim 10 , wherein the central aperture is dimensioned to receive a guide pin insertable into bone to set a position of the implant.

Continuity (3)
Continuation 17725586 · Apr 21, 2022
Provisional Application 63180239 · Apr 27, 2021
Related Publication 20250186124A1 · Jun 12, 2025
References Cited (103)
US 6231611B1 · Mosseri · 2001 [cited by applicant]
US 6395005B1 · Lovell · 2002 [cited by applicant]
US 7931690B1 · Bonutti · 2011 [cited by applicant]
US 8303665B2 · Tornier et al. · 2012 [cited by applicant]
US 8361076B2 · Roose et al. · 2013 [cited by applicant]
US 8594395B2 · Roose et al. · 2013 [cited by applicant]
US 8632597B2 · Lappin · 2014 [cited by applicant]
US 8696680B2 · Iannotti et al. · 2014 [cited by applicant]
US 8702717B2 · Rauscher et al. · 2014 [cited by applicant]
US 8747418B2 · Qureshi et al. · 2014 [cited by applicant]
US 8801725B2 · Ritter et al. · 2014 [cited by applicant]
US 8852283B2 · Tornier et al. · 2014 [cited by applicant]
US 8926627B2 · Iannotti et al. · 2015 [cited by applicant]
US 8940054B2 · Wiley et al. · 2015 [cited by applicant]
US 8992538B2 · Keefer · 2015 [cited by applicant]
US 9033990B2 · Iannotti et al. · 2015 [cited by applicant]
US 9114017B2 · Lappin · 2015 [cited by applicant]
US 9198732B2 · Iannotti et al. · 2015 [cited by applicant]
US 9226830B2 · De Wilde et al. · 2016 [cited by applicant]
US 9233003B2 · Roche et al. · 2016 [cited by applicant]
US 9283083B2 · Winslow et al. · 2016 [cited by applicant]
US 9345497B2 · Gonzalvez et al. · 2016 [cited by applicant]
US 9452055B2 · Lappin · 2016 [cited by applicant]
US 9480580B2 · White et al. · 2016 [cited by applicant]
US 9492182B2 · Keefer · 2016 [cited by applicant]
US 9526514B2 · Kelley et al. · 2016 [cited by applicant]
US 9532880B2 · Lappin · 2017 [cited by applicant]
US 9545312B2 · Tornier et al. · 2017 [cited by applicant]
US 9579107B2 · Schoenefeld · 2017 [cited by applicant]
US 9629725B2 · Gargac et al. · 2017 [cited by applicant]
US 9700325B2 · Schoenefeld · 2017 [cited by applicant]
US 9717508B2 · Iannotti et al. · 2017 [cited by applicant]
US 9741263B2 · Iannotti et al. · 2017 [cited by applicant]
US 9826994B2 · Eash et al. · 2017 [cited by applicant]
US 9844440B2 · Kovacs et al. · 2017 [cited by applicant]
US 9931168B2 · Brown et al. · 2018 [cited by applicant]
US 10028803B2 · O'Neill et al. · 2018 [cited by applicant]
US 10034757B2 · Kovacs et al. · 2018 [cited by applicant]
US 10130378B2 · Bryan · 2018 [cited by applicant]
US 10265184B2 · Lappin · 2019 [cited by applicant]
US 10271858B2 · Guilloux et al. · 2019 [cited by applicant]
US 10299807B2 · Murphy · 2019 [cited by applicant]
US 10357373B2 · Gargac et al. · 2019 [cited by applicant]
US 10357378B2 · Borries et al. · 2019 [cited by applicant]
US 10376270B2 · Eash · 2019 [cited by applicant]
US 10383735B2 · Wiley et al. · 2019 [cited by applicant]
US 10405928B2 · Falardeau et al. · 2019 [cited by applicant]
US 10433983B1 · Khosla et al. · 2019 [cited by applicant]
US 10617434B2 · Theiss et al. · 2020 [cited by applicant]
US 10813774B2 · Davenport et al. · 2020 [cited by applicant]
US 10828111B2 · Frank et al. · 2020 [cited by applicant]
US 10925658B2 · Hopkins · 2021 [cited by applicant]
US 11471290B2 · Nelson · 2022 [cited by examiner]
US 20130245632A1 · Iannotti et al. · 2013 [cited by applicant]
US 20150105696A1 · Litke et al. · 2015 [cited by applicant]
US 20150140507A1 · Moffson et al. · 2015 [cited by applicant]
US 20150190151A1 · Budhabhatti et al. · 2015 [cited by applicant]
US 20150305891A1 · Bergin et al. · 2015 [cited by applicant]
US 20160184109A1 · Davenport et al. · 2016 [cited by applicant]
US 20160242933A1 · Deransart et al. · 2016 [cited by applicant]
US 20170079742A1 · O'Neill et al. · 2017 [cited by applicant]
US 20170095336A1 · Tornier et al. · 2017 [cited by applicant]
US 20170265873A1 · Schoenefeld · 2017 [cited by applicant]
US 20180049897A1 · Lathers et al. · 2018 [cited by applicant]
US 20180125509A1 · Iannotti et al. · 2018 [cited by applicant]
US 20180303618A1 · Kovacs et al. · 2018 [cited by applicant]
US 20180333263A1 · Roby et al. · 2018 [cited by applicant]
US 20180333268A1 · Cardon et al. · 2018 [cited by applicant]
US 20180360512A1 · Mari · 2018 [cited by applicant]
US 20190015116A1 · Gargac et al. · 2019 [cited by applicant]
US 20190015117A1 · Neichel et al. · 2019 [cited by applicant]
US 20190015118A1 · Neichel et al. · 2019 [cited by applicant]
US 20190015221A1 · Neichel et al. · 2019 [cited by applicant]
US 20190151106A1 · Kovacs et al. · 2019 [cited by applicant]
US 20190159848A1 · Quaid et al. · 2019 [cited by applicant]
US 20190159907A1 · Roche et al. · 2019 [cited by applicant]
US 20190240035A1 · Lappin · 2019 [cited by applicant]
US 20190298537A1 · Gargac et al. · 2019 [cited by applicant]
US 20190343658A1 · Deransart et al. · 2019 [cited by applicant]
US 20190380792A1 · Poltaretskyi et al. · 2019 [cited by applicant]
US 20200197185A1 · Mahfouz · 2020 [cited by applicant]
US 20220296259A1 · Shah · 2022 [cited by applicant]
EP 1273269A2 · 2003 [cited by applicant]
EP 3498227A1 · 2019 [cited by applicant]
KR 102053599B1 · 2020 [cited by applicant]
WO 2012024288A2 · 2012 [cited by applicant]
WO 2012166888A2 · 2012 [cited by applicant]
WO 2013152182A1 · 2013 [cited by applicant]
WO 2014089291A1 · 2014 [cited by applicant]
WO 2017007565A2 · 2017 [cited by applicant]
WO 2017165346A1 · 2017 [cited by applicant]
WO 2018052965A1 · 2018 [cited by applicant]
WO 2018081073A1 · 2018 [cited by applicant]
WO 2019014278A1 · 2019 [cited by applicant]
WO 2020102886A1 · 2020 [cited by applicant]
WO 2020255152A1 · 2020 [cited by applicant]
WO 2021021247A1 · 2021 [cited by applicant]
European Search Report for European Patent Application No. 25184707.5 mailed Aug. 20, 2025. [cited by applicant]
Canadian Office Action for Canadian Patent Application No. 3,216,633 mailed May 1, 2025. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2022/024795 mailed Nov. 9, 2023. [cited by applicant]
International Search Report for International Application No. PCT/US2022/024795 mailed Sep. 19, 2022. [cited by applicant]
Musculoskeletal Key. Arthrex Univers Revers (TM) shoulder prosthesis. Retrieve from: https://musculoskeletalkey.com/arthrex-univers-revers-shoulder-prosthesis/. [cited by applicant]
Canadian Office Action for Canadian Patent Application No. 3,216,633 mailed May 21, 2026. [cited by applicant]